PIACENTINI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.860
EU - Europa 195
AS - Asia 93
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.150
Nazione #
US - Stati Uniti d'America 1.860
IT - Italia 84
CN - Cina 46
SG - Singapore 45
DE - Germania 25
IE - Irlanda 21
RU - Federazione Russa 16
UA - Ucraina 16
SE - Svezia 9
CZ - Repubblica Ceca 7
FI - Finlandia 4
FR - Francia 4
GB - Regno Unito 4
BE - Belgio 2
CL - Cile 1
ES - Italia 1
EU - Europa 1
NL - Olanda 1
PL - Polonia 1
TH - Thailandia 1
TR - Turchia 1
Totale 2.150
Città #
Wilmington 644
Houston 499
Woodbridge 305
Fairfield 83
Chandler 72
Rome 62
Singapore 38
Seattle 31
Cambridge 28
Ashburn 26
Dublin 21
Ann Arbor 19
Dearborn 17
Medford 16
Beijing 9
Nanjing 8
New York 8
Brno 7
Jacksonville 7
Lawrence 7
Munich 7
Santa Clara 7
Milan 6
Shanghai 6
Kunming 5
San Diego 5
Helsinki 4
Moscow 4
Nanchang 4
Wuhan 4
Guangzhou 3
Brussels 2
Hefei 2
Redwood City 2
Roseto degli Abruzzi 2
Verona 2
Amsterdam 1
Bangkok 1
Changsha 1
Chieti 1
Council Bluffs 1
Fabrica Di Roma 1
Frankfurt am Main 1
Fuzhou 1
Hangzhou 1
Kraków 1
Latina 1
London 1
Mountain View 1
Nepi 1
Norwalk 1
Novokuznetsk 1
Nuremberg 1
Paris 1
San Francisco 1
San Mateo 1
Torino 1
Tübingen 1
Totale 1.994
Nome #
Explorative genetic association study of GSTT2B copy number variant in complex disease risks 343
Second-generation nitazoxanide derivatives: Thiazolides are effective inhibitors of the influenza A virus 331
Nitazoxanide inhibits paramyxovirus replication by targeting the Fusion protein folding: role of glycoproteinspecific thiol oxidoreductase ERp57 327
The second-generation thiazolide haloxanide is a potent inhibitor of avian influenza virus replication 314
GPX1*Pro198Leu AND GPX3 rs2070593 as genetic risk markers for Italian asthmatic patients 309
Haplotype differences for copy number variants in the 22q11.23 region among human populations: A pigmentation-based model for selective pressure 294
Deletion polymorphism of GSTT1 gene as protective marker for allergic rhinitis 250
Thiazolide Prodrug Esters and Derived Peptides: Synthesis and Activity 15
The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein 10
Totale 2.193
Categoria #
all - tutte 4.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.673


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020485 0 0 0 0 62 78 75 63 72 44 46 45
2020/2021370 36 42 37 49 43 30 37 43 15 16 18 4
2021/202285 5 7 6 4 2 6 5 3 6 7 11 23
2022/2023157 12 13 15 31 4 30 17 5 22 0 5 3
2023/202433 6 0 3 2 1 8 0 0 5 1 0 7
2024/2025108 16 36 30 12 14 0 0 0 0 0 0 0
Totale 2.193